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Introduction 
Professionals working in disability services often encounter clients who have 
chromosome disorders such as Williams, Angelman or Down syndromes. As 
chromosome testing becomes increasingly sophisticated, however, more people are 
being diagnosed with very rare chromosome disorders that are identified not by a 
syndrome name, but rather by a description of the number, size and shape of their 
chromosomes (called the karyotype) or by a report of chromosome losses and gains 
detected through an advanced process known as microarray-based comparative 
genomic hybridisation (array CGH).  
For practitioners who work with individuals with rare chromosome disorders and 
their families, a basic level of knowledge about the evolving field of genetics, as well 
as specific knowledge about chromosome abnormalities, is essential since they must 
be able to demonstrate their knowledge and skills to clients (Simic & Turk, 2004). In 
addition, knowledge about the developmental consequences of various rare 
chromosome disorders is important for guiding prognoses, expectations, decisions and 
interventions.  
The current article provides information that aims to help practitioners work more 
effectively with this population. It begins by presenting essential information about 
chromosomes and their numerical and structural abnormalities and then considers the 
developmental consequences of rare chromosome disorders through a critical review 
of relevant literature. 
Chromosomes and Chromosome Abnormalities 
With the exception of egg and sperm cells and erythrocytes (red blood cells), every 
cell in the body contains 23 pairs of chromosomes that are numbered from 1 to 22 
according to their length, with 1 being the longest, plus a 23rd pair consisting of the 
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sex chromosomes, XX or XY (Therman & Susman, 1993; Turnpenny & Ellard, 
2005). Resembling long threads, chromosomes have a short arm (referred to as p) and 
a long arm (q) that are joined in the middle by a centromere. The normal complement 
of chromosomes produces 46,XX in females and 46,XY in males. Based on 
chromosome banding patterns, a numbering system is used to describe regions, bands 
and sub-bands on chromosomes. 
Occurring in 0.5 to 1% of live births, and accounting for around 50% of all 
spontaneous miscarriages, chromosome disorders result from the addition, deletion or 
rearrangement of varying amounts of chromosome material either as inherited or, 
more frequently, as spontaneous (de novo) events (Gardner & Sutherland, 2004; 
Haydon, 2008; Obe & Natarajan, 1994). Numerical anomalies involve either missing 
or extra whole chromosomes, while chromosome breakages can result in a range of 
structural disorders involving the loss or addition of varying segments of chromosome 
material. Duplications (sometimes referred to as partial trisomies) involve an extra 
copy of a chromosome segment. Deletions (also known as partial monosomies) may 
occur at the end of the chromosome (terminal) or a piece may be missing from some 
point within the chromosome (interstitial). Translocations result when the broken 
segments of two or more chromosomes exchange places. Such rearrangements are 
usually inconsequential for health and development in the carrier, provided all the 
chromosome material is still present in each cell and the translocation is thus 
“balanced”. However, there are likely to be problems with reproduction and a risk of 
unbalanced rearrangements occurring in future generations. Other chromosome 
anomalies include inversions, which result when two breakages are followed by 
reconnection of the intervening segment in reverse order, and rings that are formed 
when both chromosome tips break off and the two sticky ends fuse.  
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The most common chromosome disorder, Down syndrome, usually involves a 
third copy (trisomy) of chromosome 21 in every cell of the body. Trisomies 13 (Patau 
syndrome) and 18 (Edwards syndrome) are occasionably survivable, although they 
generally produce much more severe developmental consequences than does Down 
syndrome (Baty, Jorde, Blackburn & Carey, 1994). Trisomy mosaicism, in which 
only a proportion of cells carry the additional chromosome, has been reported for 
most chromosomes including 4 (Brady, May & Fernhoff, 2005), 8 (Habecker-Green 
et al., 1998), 12 (Staals, Schrander-Stumpel, Hamers & Fryns, 2003), 20 (Ensenauer 
et al., 2005), 21 (De A. Moreira, San Juan, Pereira & de Souza, 2000) and 22 (Florez 
& Lacassie, 2005), in some cases with no apparent detrimental effects on 
development.  
Because they occur with sufficient frequency and because their presence results in 
a distinctive phenotype, some chromosome anomalies have been classified as 
syndromes. Among the more familiar ones are Wolf-Hirschhorn, Cri du Chat, 
Williams, Smith-Magenis and Velocardiofacial (and the related DiGeorge and 
Shprintzen-Goldberg) syndromes which involve deletions on chromosomes 4p, 5p, 
7q, 17p and 22q, respectively. Turner syndrome results when only one X chromosome 
is present (producing the karyotype 45,X in affected females) while in males an 
additional copy of the X chromosome leads to Klinefelter syndrome (47,XXY). In 
most cases, Prader-Willi syndrome in caused by a deletion on 15q derived paternally 
while, intriguingly, the same deletion on the maternally derived chromosome 
produces Angelman syndrome. Other less familiar syndromes include Jacobsen 
(terminal deletion 11q) and Miller-Dieker, which involves a deletion on 17p, but at a 
breakpoint different from that occurring in Smith-Magenis syndrome.   
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There is also a wide array of less common or less distinctive chromosome 
disorders that occur in live births and it is these very rare abnormalities that are the 
focus of the current article. When diagnosed, rare chromosome disorders are given a 
label that correspond to their karyotype, such as “Duplication (9)(p22pter) with 
Deletion (11)(q23.3qter)” or “Ring (20)(p13q13.13)” rather than an actual name, 
making it difficult for families to communicate their child’s diagnosis to others and 
for service providers to categorise the disability. At times more than one chromosome 
abnormality is present, leading to complex karyotypes with as many as seven affected 
chromosomes and up to 10 separate breakpoints (Wieczorek et al., 1998). The vast 
number of possible anomalies and their extreme rarity and possible uniqueness 
sometimes lead to diagnoses that are accompanied by the pronouncement that an 
individual is the only known case in the world. However, as methods of testing 
become more advanced, more accessible and more commonly performed, it is likely 
that an increasing number of cases will be identified and reported in the literature.  
Developmental consequences of rare chromosome disorders 
Most case reports about rare chromosome disorders are published in the medical, 
rather than psychological, literature. Consequently, the focus is on genetic, medical 
and physical data with very little, if any, consideration given to cognitive, social-
emotional and behavioural outcomes. In an analysis of case reports of trisomy 17p, 
for instance, Paskulin, Zen, Rosa, Manique and Cotter (2007) provided a table of 50 
clinical findings, 49 of which were physical and medical features and just one 
developmental (specifically, neuropsychomotor delay). Only a very small number of 
papers feature detailed neuropsychological assessments (see, for example, Chilosi et 
al., 2001;  McSweeny, Wood-Gottfried, Chessare & Kurczynski, 1993; Turk, Christie, 
Sales & Surtees, 1993).  
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Among reports of developmental outcomes, characteristics such as growth 
retardation, developmental delay, intellectual disability, delayed or impaired speech, 
behaviour problems and sensory deficits are frequently mentioned. Some researchers 
have identified phenotypic patterns that appear to be associated with certain 
karyotypes including 1p36 deletion (Battaglia et al., 2008; Kang et al., 2007; 
Okamoto et al., 2002), 6q deletion (Elia et al., 2006; Striano et al., 2006), 9p deletion 
(Chilosi et al., 2001; Saha, Lloyd, Russell-Eggitt & Taylor, 2007), trisomy 17p 
(Paskulin et al., 2007) and 18q deletion (Cody et al., 2007; Semrud-Clikeman et al., 
2005). However, these studies have been based on small samples and, unlike some of 
the more common chromosome syndromes, typical features such as the hyperphagia 
seen in Prader-Willi syndrome ((Dykens, Maxwell, Pantino, Kossler, & Roof, 2007; 
Russell & Oliver, 2003) have not been reported.  
Despite a general impression of deficits and adverse developmental outcomes, the 
literature also reports individuals who appear to be developing typically in some 
respects. For example, there are reports of average intelligence in children with 
deletions on 2p (Lambert & Collinson, 1990), 6p (Chen, Cherry, Hahn & Enns, 2004), 
6q (Kumar, Cassidy, Romero & Schwartz, 1999), 8p (Gilmore, Cuskelly, Jobling & 
Smith, 2001), 11q (Carnevale, Blanco, Grether & Castillejos, 1987; Horelli-Kuitunen, 
Gahmberg, Eeva, Palotie & Järvelä, 1999; Ono et al., 1996), 18q (Strathdee, Zackai, 
Shapiro, Kamholz & Overhauser, 1995), 20p (Rovet et al., 1995), 21q (Korenberg et 
al., 1991) as well as ring chromosomes 2 (Lacassie, Arriaza, Vargas & La Motta, 
1999), 3 (McKinley, Colley, Sinclair, Donnai & Andrews, 1991), 7 (DeLozier, 
Theintz, Sizonenko & Engel, 1982), 15 (Borghgraef, Fryns & van den Berghe, 1988), 
19 (Hermsen et al., 2005) and 21 (Falik-Borenstein et al., 1992; Gardner, Monk, 
Clarkson & Allen, 1986).  
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Occasionally, surprising strengths are highlighted. For instance, Blennow and 
Bröndum-Nielsen (1990) reported that, despite moderate intellectual disability, their 
case with an 8p deletion displayed excellent memory skills and could speak two 
languages. Other authors described average abilities in isolated areas of functioning 
(Thompson, Peters & Smith, 1986) and savant skills (Rovet et al., 1995) in children 
with deletions on 18p and 20p, respectively.  
Few published reports document developmental progress at more than one point in 
time. When available, descriptions of progress over time are usually retrospective and 
dependent on the recollections of families or the availability of medical records, and 
data about developmental outcomes are limited. Melis et al. (2006) reviewed the 
progress of a child with mosaic 13q deletion annually from 13 months of age for 15 
years but the only developmental information across those years was a single IQ 
score.  
In reports of developmental outcomes, conclusions are sometimes questionable. In 
particular, claims or inferences of intellectual disability are often unsubstantiated by 
psychometric data, appearing instead to be derived from anecdotal observation or 
speculation rather than from standardised cognitive testing (e.g., Coco & 
Penchaszadeh, 1978; Moreau & Teyssier, 1982; Wieczorek et al., 1998). In the 
absence of psychometric data, evidence of abnormal cerebral imaging is sometimes 
cited as sufficient grounds for presumptions of severe intellectual disability (Feenstra, 
van Ravenswaaij, van der Knaap & Willemsen, 2006; Vermeer et al., 2007) and at 
other times useful developmental descriptions are offered to support claims of 
developmental delay (e.g., Asai et al., 1992; Grange, Garcia-Heras, Kilani, & Lamp, 
2005; Mircher et al., 2003; Sathya, Tomkins, Freeman, Paes & Nowaczyk, 1999) 
although interpretations are dubious at times. For example, Stalker, Gray, Bent-
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Williams and Zori (2006) decided that developmental milestones such as walking at 
15 months and first words at 12 months of age represented delays, when in fact both 
of these milestones are within normal limits. One of the children with a partial 2q 
duplication described by Eussen et al. (2007) as having developmental delay was 
reportedly functioning “at the level of a 4-year-old toddler” at the chronological age 
of 5 years. No assessment results were given, and no information was provided about 
the basis for this conclusion.    
Even when psychometric data are available, they are at times reported vaguely or 
inappropriately, as evidenced by descriptions of “almost normal intelligence” 
(Kitatani, Takahashi, Ozaki, Okino & Maruoka, 1990, p.138), “severe retardation, to 
between 40% and 50% of normal” (Schinzel et al., 1991, p.354) and a borderline IQ 
of 75 that was interpreted as confirmation of an assumption of severe intellectual 
disability (Paz-y-Miňo, Benitez, Ayuso & Sánchez-Cascos, 1990). Incorrect 
interpretations of IQ scores are also found. For instance, in their report of five cases 
with 6q deletion, Striano et al. (2006) wrongly classified IQs of 60 as representing 
moderate intellectual disability (cases 1 and 3), while a lower IQ of 55 was correctly 
referred to as mild intellectual disability (case 4). Netzer et al. (2006) claimed that 
their case with 18q- had ‘above average’ verbal skills, a claim that was arguably 
inaccurate and misleading in the light of an IQ of 74 (derived from five WAIS-R 
subtests) and the result of 104 on a ‘German vocabulary IQ test’. 
In summary, rare chromosome disorders have been associated with a range of 
developmental consequences including intellectual disability, language impairments 
and behaviour problems. These shared characteristics may be due to the more general 
effects of chromosome imbalance, rather than specific anomalies. At the same time, 
evidence about normal intelligence in some individuals with rare chromosome 
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abnormalities suggests that adverse developmental outcomes are not necessarily 
inevitable.  
These conclusions about development are, however, drawn from a relatively 
limited literature base that is inadequate in some respects. Because it is likely that 
cases with more negative developmental outcomes are being diagnosed and reported, 
the literature may not be accurately portraying the range of possible outcomes that are 
attainable. Moreover, data are usually collected at only one point in time, 
comprehensive assessment batteries are rare, and interpretations of results are not 
always rigorous. In particular, conclusions about intellectual functioning are 
sometimes vague or unsubstantiated.  
Implications for practitioners 
Clearly, the limited literature about the developmental consequences of rare 
chromosome disorders makes it difficult for practitioners to work effectively with this 
population. Most rare chromosome disorders occur, or are identified, so infrequently 
that their developmental course has not yet been well documented and at times it is 
impossible to locate a single published case matching the karyotype of an individual 
seen in clinical practice (Gilmore & Campbell, 2006).  
Even when appropriate literature is available, the developmental data can be 
sparse, inadequate or inconsistent, and consequently practitioners need to search and 
evaluate the literature carefully and critically, with an awareness of its limitations. For 
example, assertions in the literature about the inevitability of certain outcomes (e.g., 
“mental retardation is always present” in Mircher et al., 2003, p.177) need to be 
examined and rejected if they are based on small samples and inadequate or non-
existent psychometric data. 
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Practitioners should also seek sources of information beyond the academic and 
professional literature. Of particular value is the Unique Rare Chromosome Disorder 
Support Group (www.rarechromo.org) which has established a rich database 
containing the developmental histories of more than 6,900 individuals with a rare 
chromosome disorder. Their descriptive data, collected worldwide and periodically 
since 1984, track development across all domains including cognitive and 
behavioural, thus providing an exceptional resource for families and professionals. In 
addition, Unique and other support groups provide a range of services, advice and 
support, including valuable contact with other families whose children have the same, 
or similar chromosome abnormalities.  
Because of the notable within-group variability that characterises some 
chromosome abnormalities, prognoses about future development need to be tentative, 
taking into consideration the range of possible outcomes that have been documented 
in the literature, as well as the unique individual, family and contextual characteristics 
that are also likely to influence developmental outcomes. In particular, developmental 
predictions need to be sensitively expressed, since the prognostic uncertainty 
associated with rare chromosome disorders is likely to produce significant emotional 
stress and anxiety for families (Lenhard, Breitenbach, Ebert, Schindelhauer-Deutscher 
& Henn, 2005).  
There may well be grounds for being cautiously optimistic about future 
development and indeed, as Baty et al. (1994) have pointed out, families tend to 
resent early negative prognoses, irrespective of whether or not they are well-informed 
and well-intentioned, and to appreciate acknowledgments of their children’s strengths 
and accomplishments. Families may benefit from clear explanations about the cause 
of their child’s chromosome abnormality (e.g., an accident in cell division around the 
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time of conception or the inheritance of an unbalanced translocation from one parent) 
and guidance on how to explain their child’s diagnosis to others, particularly since the 
overwhelming majority of diagnoses are not associated with a syndrome name. 
Finally, practitioners may have opportunities to contribute to the research literature 
by producing developmental case studies of individuals with rare chromosome 
disorders. Case studies have the potential to provide rich data about cognitive, 
behavioural, social, academic and personal development that can illuminate 
developmental processes and trajectories. Despite limited generalisability, case 
reports represent the only viable research methodology for karyotypes that are so truly 
unique that obtaining an adequate sample for systematic investigation appears 
impossible or unlikely. An increasing number of reports that include robust data about 
developmental outcomes will provide a stronger knowledge base to guide prognoses, 
ongoing supports and services, and specific interventions for individuals with rare 
chromosome disorders.  
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